SAE case processing – Clinical Research Made Simple

SOP for SAE and DSUR Reporting to Health Canada

August 18, 2025

SOP for SAE and DSUR Reporting to Health Canada { “@context”: “https://schema.org”, “@type”: “Article”, “mainEntityOfPage”: { “@type”: “WebPage”, “@id”: “https://www.clinicalstudies.in/sae-dsur-reporting-health-canada” }, “@id”: “https://www.clinicalstudies.in/sae-dsur-reporting-health-canada”, “headline”: “SOP for SAE and DSUR Reporting to Health Canada”, “name”: “SOP for SAE and DSUR Reporting to Health Canada”, “description”: “Comprehensive SOP defining processes, timelines, and responsibilities for reporting Serious Adverse…

Health Canada — Unique SOPs (Canada), SOP for GCP

How to Manage Unexpected SAEs in Ongoing Clinical Trials

July 4, 2025

digi

How to Manage Unexpected SAEs in Ongoing Clinical Trials Effective Management of Unexpected SAEs in Ongoing Clinical Trials Unexpected Serious Adverse Events (SAEs) can arise at any point during a clinical trial and often require immediate, coordinated, and compliant action by both investigators and sponsors. These unanticipated events not only pose risk to participant safety…

Safety Reporting and Pharmacovigilance, Serious Adverse Event (SAE) Management